Literature DB >> 498110

Comparative biological and biochemical effects of nogalamycin and its analogs on L1210 leukemia.

L H Li, S L Kuentzel, L L Murch, L M Pschigoda, W C Krueger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 498110

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  18 in total

1.  Anthracycline antibiotic arugomycin binds in both grooves of the DNA helix simultaneously: an NMR and molecular modelling study.

Authors:  M S Searle; W Bicknell; L P Wakelin; W A Denny
Journal:  Nucleic Acids Res       Date:  1991-06-11       Impact factor: 16.971

2.  A phase II study of menogaril in low-grade non-Hodgkin's lymphoma. An NCI Canada Clinical Trials Group study.

Authors:  J Skillings; C Cripps; E Eisenhauer; J Pater; S Verma; D Walde
Journal:  Invest New Drugs       Date:  1991-02       Impact factor: 3.850

3.  Structure of nogalamycin bound to a DNA hexamer.

Authors:  L D Williams; M Egli; G Qi; P Bash; G A van der Marel; J H van Boom; A Rich; C A Frederick
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

Review 4.  Mechanism of DNA-drug interactions.

Authors:  P Prabhakar; A M Kayastha
Journal:  Appl Biochem Biotechnol       Date:  1994-04       Impact factor: 2.926

5.  Conformation and dynamics of the deoxyribose rings of a (nogalamycin)2-d (5'-GCATGC)2 complex studied in solution by 1H-n.m.r. spectroscopy.

Authors:  M S Searle; L P Wakelin
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

6.  Menogaril: a new anthracycline agent entering clinical trials.

Authors:  J P McGovren; K G Nelson; M Lassus; J C Cradock; J Plowman; J P Christopher
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

7.  Phase I clinical and pharmacokinetic study of menogaril (7-con-O-methylnogarol) in previously treated patients with acute leukemia.

Authors:  C Mazurek; J P Dutcher; E L Schwartz; S Garl; L Benson; P H Wiernik
Journal:  Invest New Drugs       Date:  1993-11       Impact factor: 3.850

8.  Synergistic combination of menogarol and melphalan and other two drug combinations.

Authors:  B K Bhuyan; E G Adams; M Johnson; S L Crampton
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

9.  Pharmacokinetics of 7-con-O-methylnogarol in patients with solid tumors.

Authors:  M L Zanette; U Tirelli; R Sorio; D Zadro; F Figoli; S Monfardini; M D'Incalci
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

10.  Structure and activity relationship of several novel CC-1065 analogs.

Authors:  L H Li; T L Wallace; T F DeKoning; M A Warpehoski; R C Kelly; M D Prairie; W C Krueger
Journal:  Invest New Drugs       Date:  1987-12       Impact factor: 3.850
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.